Ivarmacitinib (SHR0302)

Chemical Structure : Ivarmacitinib

CAS No.: 1445987-21-2

加入收藏

货号: PC-73423Not For Human Use, Lab Use Only.

Ivarmacitinib (SHR0302) is a potent highly selective, Janus kinase 1 (JAK1) inhibitor with IC50 of 0.1 nM, 9-fold selectivity over JAK2 and >70-fold over JAK3 and TYK2.

规格	价格	库存
2 mg	￥1980	In stock
5 mg	￥3280	In stock
10 mg	￥5280	In stock
25 mg	￥8980	In stock
50 mg		Get quote
100 mg		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

Ivarmacitinib (SHR0302) is a potent highly selective, Janus kinase 1 (JAK1) inhibitor with IC50 of 0.1 nM, 9-fold selectivity over JAK2 and >70-fold over JAK3 and TYK2.
SHR0302 is a synthetic molecule that potently inhibits all members of the JAK family, particularly JAK1.
SHR0302 suppressed the severity of adjuvant-induced arthritis (AA) rats by attenuating the arthritis index, arthritis global assessment and paw swelling degree, and alleviated histopathology of spleen and joint of AA rats.
SHR0302 inhibited the proliferation of T, B and FLS, and down-regulated cytokines TNF-α, IL-1β, IL-17 and antibody IgG1, IgG2a levels, and suppressed the proportion of Th17 and total B, and inhibited JAK1-STAT3 phosphorylation.
SHR0302 (1-10,000 nM) exerted an inhibitory effect on the activation, proliferation and migration of hepatic stellate cells (HSCs).

物理化学性质&存储条件

分子量	414.488
分子式	C18H22N8O2S
外观性状	Solid
CAS No.
储存条件	固体粉末 -20°C 12 个月; 4°C 6 个月	配置液 -80°C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	rel-(3aR,5s,6aS)-N-(3-Methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxamide

参考文献

1. Wu H, et al. Joint Bone Spine. 2016 Oct;83(5):525-32.

2. Gu YJ, et al. Int J Mol Med. 2016 Sep;38(3):903-11.

3. Zhao Y, et al. Am J Clin Dermatol. 2021 Nov;22(6):877-889.